Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuadrise Regulatory News (QED)

Share Price Information for Quadrise (QED)

Share Price is delayed by 15 minutes
Get Live Data
1.85    0.05 (2.78%)
Bid:
1.50
Ask:
1.85
Spread: 0.35 (23.333%)
Market Cap: £37.11m
QED Live PriceLast checked at - London Stock Exchange

Intraday Quadrise Share Chart

Disposal

11 Sep 2009 07:00

RNS Number : 8892Y
Quintain Estates & Development PLC
11 September 2009
 



11 September 2009 

Quintain Estates & Development plc

("Quintain" / "Company" / "Group")

QUINTAIN REPATRIATES A FURTHER £31.3 MILLION OF CASH

Quintain announces the sale of units in The Quercus Healthcare Property Partnership ("Quercus" / the "Fund"for a total cash consideration of £31.3 million. The units have been sold to a number of UK institutional pension funds through the anonymous matched bargain dealing facility provided by Aviva Investors, Quintain's partner in the Fund.

This transaction was undertaken as part of Quintain's strategy to repatriate cash and reduce gearing, thereby enhancing the Company's financial flexibility. The proceeds of the disposal bring the total amount of cash repatriated since 1 April 2009 to over £42 million, representing 85% of the £50 million Quintain had targeted to raise in the year to 31 March 2010. The total cash repatriated by the Group since 1 April 2008 is now £140 million. 

Quercus is the largest fund within Quintain Fund Management. As at 30 June 2009, it had £759.9 million in funds under management and owned 264 assets, comprising nursing and residential care homes for the elderly, specialist care homes for those with long term disabilities, private hospitals, and care villages. The units were sold at a 12% discount to the Fund's reported NAV at July and a discount to Quintain's March valuation of £10.8mrepresenting a loss against book cost of £1.8 million. In the last twelve months, the units delivered £2.5 million of income to the Group

As a result of this disposalQuintain's total holding in Quercus is reduced from 25.4% to 16% and the number of investors in the Fund has increased to 50.

Rebecca Worthington, Finance Director of Quintain, commented: 

"This disposal represents another important milestone in our cash repatriation programme, taking the total raised to 85% of the £50 million we intend to repatriate by 31 March 2010 and thereby further enhancing Quintain's financial flexibility and control over interest costs."

For further information, please contact:

Quintain Estates & Development plc

Rebecca Worthington / Tonianne Dwyer / Cressida Curtis

Tel: +44 (0) 20 7495 8968

Financial Dynamics

Stephanie Highett / Dido Laurimore / Laurence Jones 

Tel: +44 (0) 20 7831 3113

Notes to Editors

Quintain Fund Management ("QFM") uses specialist property expertise to create value in its funds operating in three sectors with high barriers to entry: healthcare (Quercus), student accommodation (iQ) and science parks (Quantum). Each fund is underpinned by strong demographics such as an ageing population and increasing numbers of people entering higher education. The Funds interact with Quintain's other businesses, taking space on our major schemes, using the asset management skills within the Investment Portfolio and generating income that is used across the Group.

As at 31 March 2009, QFM's funds under management were £980 million.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISILFSRAIIILIA
Date   Source Headline
20th Jun 20149:30 amRNSAnnual Report and Notice of AGM
9th Jun 20144:30 pmRNSDirector/PDMR Shareholding
3rd Jun 20144:30 pmRNSDirector/PDMR Shareholding
3rd Jun 20144:30 pmRNSTotal Voting Rights
2nd Jun 20144:31 pmRNSBlocklisting Interim Review
2nd Jun 20144:30 pmRNSHolding(s) in Company
28th May 20144:30 pmRNSHolding(s) in Company
28th May 20144:29 pmRNSAdditional Listing
27th May 20144:30 pmRNSDirector/PDMR Shareholding
23rd May 20147:00 amRNSFinal Results for the year ended 31 March 2014
16th May 20147:00 amRNSDisposal of share in iQ JV to Wellcome Trust
8th May 20149:01 amRNSNotice of Results
7th May 20144:30 pmRNSDirector/PDMR Shareholding
2nd May 20144:01 pmRNSTotal Voting Rights
2nd May 20144:00 pmRNSDirector/PDMR Shareholding
1st May 20147:00 amRNSQuintain acquires Aldermary House, EC4
14th Apr 20147:00 amRNSRe Joint Venture at Wembley Park
11th Apr 20144:38 pmRNSHolding(s) in Company
9th Apr 20144:31 pmRNSReplacement Director/PDMR Shareholding
2nd Apr 20144:31 pmRNSTotal Voting Rights
2nd Apr 20144:30 pmRNSDirector/PDMR Shareholding
26th Mar 20144:30 pmRNSHolding(s) in Company
26th Mar 20143:00 pmRNSDirector Declaration
11th Mar 20149:03 amRNSDirector/PDMR Shareholding
4th Mar 20144:31 pmRNSTotal Voting Rights
4th Mar 20144:30 pmRNSDirector/PDMR Shareholding
14th Feb 20145:17 pmRNSHolding(s) in Company
12th Feb 20144:30 pmRNSHolding(s) in Company
12th Feb 20147:00 amRNSDisposal of interest in Mitre Passage
12th Feb 20147:00 amRNSInterim Management Statement
7th Feb 20147:00 amRNSQuintain acquires Kingsbourne House
4th Feb 20144:31 pmRNSTotal Voting Rights
4th Feb 20144:28 pmRNSDirector/PDMR Shareholding
30th Jan 20144:30 pmRNSDirector/PDMR Shareholding
7th Jan 20144:32 pmRNSBlocklisting Interim Review
7th Jan 20144:31 pmRNSBlocklisting Interim Review
7th Jan 20144:30 pmRNSTotal Voting Rights
7th Jan 20144:30 pmRNSDirector/PDMR Shareholding
7th Jan 20144:30 pmRNSDirector/PDMR Shareholding
27th Dec 20139:43 amRNSHolding(s) in Company
10th Dec 20139:30 amRNSDirector/PDMR Shareholding
5th Dec 20131:05 pmRNSHolding(s) in Company
3rd Dec 20139:30 amRNSHolding(s) in Company
3rd Dec 20139:06 amRNSTotal Voting Rights
3rd Dec 20139:05 amRNSDirector/PDMR Shareholding
25th Nov 20137:00 amRNSResults for the six months ended 30 September 2013
21st Nov 20131:15 pmRNSGeneral Meeting voting results
8th Nov 20134:00 pmRNSNotice of Interim Results
7th Nov 20134:30 pmRNSDirector/PDMR Shareholding
7th Nov 201311:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.